Cerenome (CNSY) EBIT Margin Growth (5y) (2016 - 2024)
Powered by 
Analysis
Cerenome (CNSY) EBIT Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 11,139.00 |
| Dec 31, 2023 | -15,951.00 |
| Sep 30, 2023 | 18,567.00 |
| Jun 30, 2023 | 20,128.00 |
| Mar 31, 2023 | -33,785.00 |
| Dec 31, 2022 | -314,173.00 |
| Sep 30, 2022 | -604,810.00 |
| Mar 31, 2019 | 61,789.00 |
| Dec 31, 2018 | 20,260.00 |
| Sep 30, 2018 | 26,402.00 |
| Jun 30, 2018 | 17,222.00 |
| Mar 31, 2018 | -11,137.00 |
| Dec 31, 2017 | -47,874.00 |
| Sep 30, 2017 | -14,368.00 |
| Jun 30, 2017 | -21,848.00 |
| Mar 31, 2017 | -64,144.00 |
| Dec 31, 2016 | 4,283.00 |
| Sep 30, 2016 | -28,964.00 |
| Jun 30, 2016 | -37,142.00 |
| Mar 31, 2016 | 44,311.00 |